SIRT2 and Huntington disease: The characteristic pattern observed in preclinical findings could not be confirmed on human samples, where Sirt1, -2, and -3 mRNA levels were assessed, demonstrating elevated cortical and striatal Sirt1 and striatal Sirt2 expression in HD patients without any change regarding Sirt3 or the cerebellum [4].